KPMG will be hosting a series of events alongside the 44th annual J.P. Morgan Healthcare Conference. Additionally, as in years past, we will be launching our 2026 Investment Outlook the week of the conference, offering insights into the trends shaping life sciences and healthcare.
Join us to hear from leading industry visionaries, innovative technology creators, emerging growth companies, and members of the investment community. Gain forward-looking perspectives on critical topics that will define the future of healthcare and life sciences.
If you’re planning to be in San Francisco for the J.P. Morgan Healthcare Conference, we want to connect with you!
Add KPMG to your agenda:
KPMG and Kirkland & Ellis panels
Date: Monday, January 12, 2026
Time: 4:00pm – 5:30pm
Location: Kirkland & Ellis Office, 555 California Street, 30th Floor, San Francisco, CA 94104
This annual event will dive into strategies for positioning physician enterprises for long-term success. Topics will include structuring service offerings to meet market needs, optimizing operations for efficiency, and aligning resources to drive sustainable growth. Attendees will gain actionable insights on building scalable, patient-focused organizations that deliver value in an evolving healthcare and life sciences landscape.
Transformative and Innovative Deals and Value Creation for Health Systems and Their Partners
KPMG Moderator: Ross Nelson, MD, Healthcare Deal Advisory & Strategy Sector Leader
Panelists: Kristin Pothier, Global HCLS Deal Advisory & Strategy Leader, KPMG, Tripp Shubert, VP Strategic Ventures, Bon Secours Mercy Health and Sami Yusuf, Chair, Corporate Development, Mayo Clinic
As the healthcare landscape evolves, physician enterprises face mounting pressure to expand their footprint, diversify service offerings, and streamline operations. This panel will explore strategies for sustainable growth and operational excellence.
Balancing Opportunity and Risk in Healthcare Tech M&A: Optimizing Data Value under Growing Scrutiny
Kirkland & Ellis Speakers: Dennis Williams and Rob Kantrowitz
As health data becomes central to AI, marketing, and analytics strategies that make targets appealing, the regulatory and legal framework presents increasing obstacles. The speakers will explore how investors and operators may unlock the value of acquired data assets while staying ahead of enforcement trends and evolving privacy frameworks. Specifically, this conversation will highlight (1) key economic and operational value data can deliver to healthcare technology investments and (2) governance, diligence, and structuring considerations to help mitigate risk and enable innovation at scale.
KPMG Cocktail Reception
Date: Tuesday, January 13, 2026
Time: 6:00pm – 8:30pm
Location: Nave Bar (at Hotel Stratford), 242 Powell Street, San Francisco, CA 94102
Thank you for your interest! Unfortunately, we are over-subscribed for this event and have now closed registration.
KPMG + Goodwin Symposium
Date: Wednesday, January 14, 2026
Time: 8:30am – 6:30pm
Location: InterContinental Hotel, 888 Howard Street, San Francisco, CA 94103
Goodwin and KPMG are excited to host our 7th annual Symposium. This event brings together industry leaders to explore the latest trends in AI-driven drug discovery, creative strategies for liquidity in a challenging market, and the evolving healthcare investment landscape. Highlights include panels on innovative financing, M&A in a shifting legal environment, global dealmaking with a focus on China, and a keynote conversation with the CEO of Blueprint Medicines. Don’t miss this opportunity to connect with peers and gain actionable perspectives on the future of life sciences.
Meet our team
For more information on these events or to request an invitation, please contact a member of our team listed below.
Meet our life sciences leadership team:
Meet our healthcare leadership team:
Explore more
KPMG 2025 Healthcare & Life Sciences Investment Outlook
Our annual in-depth examination of the healthcare and life sciences deal market explores 2024 and the year ahead.
Enhancing precision medicine R&D processes
How life sciences companies can navigate the R&D complexities associated with precision medicines
Pharma services: Rethinking R&D for speed and impact
Pharma firms are transforming R&D by streamlining spend, embracing tech, and outsourcing to boost efficiency and impact.